Skip to main content

Table 1 Clinical and Biological characteristics of patients with Neuroblastoma evaluated according to tumour ploidy status.

From: Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status

Case number ploidy Age INSS stage MYCN amplification Disease Status Survival Status microarray analysis validation analysis
   <12m=0; >12m=1 1,2,3,4s=0; 4=1      
1 near-3n 1 0 NA NP A Y Y
2 near-3n 1 0 NA NP A Y .
3 near-3n 1 0 NA NP A Y Y
4 near-3n 0 0 NA NP A Y .
5 near-3n 0 0 NA NP A Y Y
6 near-3n 0 0 NA NP A Y .
7 near-3n 0 0 NA P A Y .
8 near-3n 0 0 NA P A Y .
9 near-3n 0 0 NA NP A Y .
10 near-3n 0 0 NA NP A Y .
11 near-3n 1 0 NA NP A Y Y
12 near-3n 0 0 NA NP A Y .
13 near-3n 1 1 NA P D Y .
14 near-3n 1 0 NA NP A Y .
15 near-3n 0 0 NA NP A Y Y
16 near-3n 0 0 NA NP A Y .
17 near-3n 0 0 NA P A Y Y
18 near-3n 1 1 NA P D Y Y
19 near-3n 1 0 NA NP A Y .
20 near-3n 1 0 NA NP A Y Y
21 near-3n 0 0 NA P A Y .
22 near-3n 1 0 NA P D Y Y
23 near-3n 0 0 NA NP A . Y
24 near-3n 0 0 NA NP A . Y
25 near-3n 0 0 NA NP A . Y
26 near-3n 0 0 NA NP A . Y
27 near-3n 1 0 NA NP A . Y
28 near-3n 1 0 NA NP A . Y
29 near-3n 1 0 NA NP A . Y
30 near-3n 1 0 NA NP A . Y
31 near-3n 0 1 NA NP A . Y
32 near-3n 0 0 NA NP A . Y
33 near-3n 1 1 NA P A . Y
34 near-3n 0 0 NA NP A . Y
35 near-3n 0 0 NA P D . Y
36 near-3n 0 0 NA NP A . Y
37 near-3n 0 0 NA NP A . Y
38 near-2n 1 1 A NP A Y Y
39 near-2n 1 1 A P D Y Y
40 near-2n 1 0 NA P D Y .
41 near-2n 1 1 A P D Y Y
42 near-2n 1 1 A P A Y Y
43 near-2n 1 1 NA NP A Y Y
44 near-2n 1 1 NA P D Y .
45 near-2n 1 1 A P D Y .
46 near-2n 1 1 NA NP A Y .
47 near-2n 1 0 NA P D Y .
48 near-2n 1 0 NA P D Y .
49 near-2n 0 1 A NP A Y .
50 near-2n 0 0 NA NP A Y Y
51 near-2n 0 0 NA P A Y .
52 near-2n 1 1 A P D Y Y
53 near-2n 1 0 A NP A Y Y
54 near-2n 1 0 NA NP A Y .
55 near-2n 1 1 NA P D Y Y
56 near-2n 0 0 NA P A Y .
57 near-2n 0 0 NA NP A Y .
58 near-2n 1 1 NA P D Y .
59 near-2n 1 1 NA P D Y Y
60 near-2n 1 0 NA P D Y .
61 near-2n 0 0 NA NP A . Y
62 near-2n 1 1 NA P D . Y
63 near-2n 1 1 A P D . Y
64 near-2n 1 1 NA NP A . Y
65 near-2n 1 1 NA P D . Y
66 near-2n 0 0 A NP A . Y
67 near-2n 1 1 A P D . Y
68 near-2n 1 1 NA P A . Y
69 near-4n 1 0 NA NP A Y .
70 near-4n 0 1 A P D Y Y
71 near-4n 1 1 NA NP A Y Y
72 near-4n 0 1 NA P A Y .
73 near-4n 1 0 A P D . Y
74 near-4n 1 1 A P D . Y
  1. MYCN amplification status: NA = not amplified, A = amplified. Disease status: NP = no disease progression, P = disease progression. Survival status: A = alive, D = dead. Microarray and validation analyses: Y = cases analyzed.
Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us